Compared to normal tissues, the expression of IL-17B was downregulated in most tumors except CHOL, GBM, and LIHC (p < 0.01), and the expression of IL-17C was upregulated in all tumors except KICH (p < 0.01). This evidence concerns the gene IL17B and glioblastoma.